Maxitrol - 0998-0630-06 - (neomycin sulfate, polymyxin b sulfate and dexamethasone)

Alphabetical Index


Drug Information of Maxitrol

Product NDC: 0998-0630
Proprietary Name: Maxitrol
Non Proprietary Name: neomycin sulfate, polymyxin b sulfate and dexamethasone
Active Ingredient(s): 1; 3.5; 10000    mg/mL; mg/mL; [USP'U]/mL & nbsp;   neomycin sulfate, polymyxin b sulfate and dexamethasone
Administration Route(s): OPHTHALMIC
Dosage Form(s): SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Maxitrol

Product NDC: 0998-0630
Labeler Name: Alcon Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050023
Marketing Category: NDA
Start Marketing Date: 19641115

Package Information of Maxitrol

Package NDC: 0998-0630-06
Package Description: 5 mL in 1 BOTTLE, PLASTIC (0998-0630-06)

NDC Information of Maxitrol

NDC Code 0998-0630-06
Proprietary Name Maxitrol
Package Description 5 mL in 1 BOTTLE, PLASTIC (0998-0630-06)
Product NDC 0998-0630
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name neomycin sulfate, polymyxin b sulfate and dexamethasone
Dosage Form Name SUSPENSION
Route Name OPHTHALMIC
Start Marketing Date 19641115
Marketing Category Name NDA
Labeler Name Alcon Laboratories, Inc.
Substance Name DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength Number 1; 3.5; 10000
Strength Unit mg/mL; mg/mL; [USP'U]/mL
Pharmaceutical Classes Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of Maxitrol


General Information